UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Treatment‐specific evaluation of the modified Glasgow‐Prognostic‐Score in patients with advanced cutaneous melanoma

Journal of the European Academy of Dermatology and Venereology, 2021-12, Vol.35 (12), p.e879-e883

2021

Volltextzugriff (PDF)

P12.05 Cellular biosensors to study protein interactions relevant to immunotherapy

Journal for immunotherapy of cancer, 2024-03, Vol.12 (Suppl 1), p.A33-A33

2024

Volltextzugriff (PDF)

PRIORITISATION OF RELEVANT COCHRANE REVIEW TOPICS IN THE FIELD OF HAEMATOLOGY

Hematological oncology, 2021-06, Vol.39 (S2)

2021

Volltextzugriff (PDF)

P06.02 Spatio-functional characterization of tumor-infiltrating B cells in the tumor microenvironment of cutaneous T cell lymphoma

Journal for immunotherapy of cancer, 2024-03, Vol.12 (Suppl 1), p.A23-A24

2024

Volltextzugriff (PDF)

P10.01 Nutritional and immunometabolic measures for risk assessment in allogeneic hematopoietic stem cell transplantation

Journal for immunotherapy of cancer, 2024-03, Vol.12 (Suppl 1), p.A28-A29

2024

Volltextzugriff (PDF)

Hypoxia-induced p38 MAPK activation reduces Mcl-1 expression and facilitates sensitivity towards BH3 mimetics in chronic lymphocytic leukemia

Leukemia, 2015-04, Vol.29 (4), p.981-984

2015

Volltextzugriff (PDF)

P09.01 Adapting immune cells to the hypoglycemic tumor microenvironment by solute carrier 2a1 (Slc2a1/GLUT1) overexpression

Journal for immunotherapy of cancer, 2024-03, Vol.12 (Suppl 1), p.A25-A25

2024

Volltextzugriff (PDF)

Plerixafor with and without chemotherapy in poor mobilizers: results from the German compassionate use program

Bone marrow transplantation (Basingstoke), 2011-08, Vol.46 (8), p.1045-1052

2011

Volltextzugriff (PDF)

P1402: ALTERATIONS OF HUMAN BONE MARROW NICHE IN CLONAL HEMATOPOIESIS AND AML

HemaSphere, 2022-06, Vol.6 (Suppl), p.1286-1287

2022

Volltextzugriff (PDF)

Reply to 'The correlation between cotransplantation of mesenchymal stem cells and higher recurrence rates in hematologic malignancy patients: outcome of a pilot clinical study' by Ning et al

Leukemia, 2009-01, Vol.23 (1), p.178; author reply 179-178

2009

Volltextzugriff (PDF)

Risk-adapted, treosulfan-based therapy with auto- and allo-SCT for relapsed/refractory aggressive NHL: a prospective phase-II trial

Bone marrow transplantation (Basingstoke), 2014-03, Vol.49 (3), p.410-415

2014

Volltextzugriff (PDF)

Nonmyeloablative allogeneic stem cell transplantation for chronic lymphocytic leukaemia offers the possibility of disease control with minimal morbidity and mortality—a single institution experience

Annals of hematology, 2015-10, Vol.94 (10), p.1717-1725

2015

Volltextzugriff (PDF)

Donor lymphocyte infusions combined with systemic PUVA/bexarotene as an effective bimodal immunologic approach in a patient with relapsed cutaneous T cell lymphoma after allogeneic stem cell transplantation

Transplant immunology, 2011-09, Vol.25 (2), p.163-166

2011

Volltextzugriff (PDF)

Human herpesvirus‐6 as an inducer of porphyria cutanea tarda: implications from a case

Transplant infectious disease, 2010-10, Vol.12 (5), p.432-436

2010

Volltextzugriff (PDF)

63P Obesity and sarcopenia as biomarkers for immunotherapy outcomes: A systematic review and meta-analysis

Annals of oncology, 2021-09, Vol.32, p.S384-S384

2021

Volltextzugriff (PDF)

Human parvovirus B19 infection with GvHD-like erythema in two allogeneic stem cell transplant recipients

Bone marrow transplantation (Basingstoke), 2007-03, Vol.39 (5), p.315-316

2007

Volltextzugriff (PDF)

Role of stem cell transplantation in treatment of primary cutaneous T‑cell lymphoma

Hautarzt, 2017-09, Vol.68 (9), p.716-720

2017

Volltextzugriff (PDF)

PO-1159 Stereotactic radiosurgery and combined immunotherapy with ipilimumab and nivolumab for melanoma brain metastases

Radiotherapy and oncology, 2022-05, Vol.170, p.S983-S984

2022

Volltextzugriff (PDF)

PH-0525: Radio-immunotherapy versus immunotherapy alone – tolerance and adverse events

Radiotherapy and oncology, 2020-11, Vol.152, p.S287-S288

2020

Volltextzugriff (PDF)

Lower protein content in infant formula reduces BMI and obesity risk at school age: follow-up of a randomized trial

The American journal of clinical nutrition, 2014-05, Vol.99 (5), p.1041-1051

2014

Volltextzugriff (PDF)

PO-0890 Abscopal effects in metastasized cancer patients treated with PD-1 inhibition and radiation therapy

Radiotherapy and oncology, 2019-04, Vol.133, p.S470-S471

2019

Volltextzugriff (PDF)

Nongenotoxic activation of the p53 pathway as a therapeutic strategy for multiple myeloma

Blood, 2005-11, Vol.106 (10), p.3609-3617

2005

Volltextzugriff (PDF)

P01.06 Overweight and obesity as biomarkers for survival outcomes and immune related adverse events undergoing immunotherapy – a systematic review and meta-analysis

Journal for immunotherapy of cancer, 2021-10, Vol.9 (Suppl 1), p.A5-A6

2021

Volltextzugriff (PDF)

P01.08 Sarcopenia as biomarker for immunotherapy outcomes and immune-related adverse events – a systematic review and meta-analysis

Journal for immunotherapy of cancer, 2021-10, Vol.9 (Suppl 1), p.A7-A7

2021

Volltextzugriff (PDF)

P01.18 Metabolic status and immune activation influence clinical outcomes in patients after allogeneic hematopoietic stem cell transplantation

Journal for immunotherapy of cancer, 2020-10, Vol.8 (Suppl 2), p.A17-A17

2020

Volltextzugriff (PDF)

1 – 25 von 276

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(245)
Mit Volltextzugriff
(232)

Publikationsform

3 weitere anzeigen...

Weniger anzeigen...

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

Menü

Weitere Dienste

Einstellungen

Treatment‐specific evaluation of the modified Glasgow‐Prognostic‐Score in patients with advanced cutaneous melanoma

P12.05 Cellular biosensors to study protein interactions relevant to immunotherapy

PRIORITISATION OF RELEVANT COCHRANE REVIEW TOPICS IN THE FIELD OF HAEMATOLOGY

P06.02 Spatio-functional characterization of tumor-infiltrating B cells in the tumor microenvironment of cutaneous T cell lymphoma

P10.01 Nutritional and immunometabolic measures for risk assessment in allogeneic hematopoietic stem cell transplantation

Hypoxia-induced p38 MAPK activation reduces Mcl-1 expression and facilitates sensitivity towards BH3 mimetics in chronic lymphocytic leukemia

P09.01 Adapting immune cells to the hypoglycemic tumor microenvironment by solute carrier 2a1 (Slc2a1/GLUT1) overexpression

Plerixafor with and without chemotherapy in poor mobilizers: results from the German compassionate use program

P1402: ALTERATIONS OF HUMAN BONE MARROW NICHE IN CLONAL HEMATOPOIESIS AND AML

Reply to 'The correlation between cotransplantation of mesenchymal stem cells and higher recurrence rates in hematologic malignancy patients: outcome of a pilot clinical study' by Ning et al

Risk-adapted, treosulfan-based therapy with auto- and allo-SCT for relapsed/refractory aggressive NHL: a prospective phase-II trial

Nonmyeloablative allogeneic stem cell transplantation for chronic lymphocytic leukaemia offers the possibility of disease control with minimal morbidity and mortality—a single institution experience

Donor lymphocyte infusions combined with systemic PUVA/bexarotene as an effective bimodal immunologic approach in a patient with relapsed cutaneous T cell lymphoma after allogeneic stem cell transplantation

Human herpesvirus‐6 as an inducer of porphyria cutanea tarda: implications from a case

63P Obesity and sarcopenia as biomarkers for immunotherapy outcomes: A systematic review and meta-analysis

Human parvovirus B19 infection with GvHD-like erythema in two allogeneic stem cell transplant recipients

Role of stem cell transplantation in treatment of primary cutaneous T‑cell lymphoma

PO-1159 Stereotactic radiosurgery and combined immunotherapy with ipilimumab and nivolumab for melanoma brain metastases

PH-0525: Radio-immunotherapy versus immunotherapy alone – tolerance and adverse events

Lower protein content in infant formula reduces BMI and obesity risk at school age: follow-up of a randomized trial

PO-0890 Abscopal effects in metastasized cancer patients treated with PD-1 inhibition and radiation therapy

Nongenotoxic activation of the p53 pathway as a therapeutic strategy for multiple myeloma

P01.06 Overweight and obesity as biomarkers for survival outcomes and immune related adverse events undergoing immunotherapy – a systematic review and meta-analysis

P01.08 Sarcopenia as biomarker for immunotherapy outcomes and immune-related adverse events – a systematic review and meta-analysis

P01.18 Metabolic status and immune activation influence clinical outcomes in patients after allogeneic hematopoietic stem cell transplantation

Suchergebnisse filtern